Ellume, page-167

Plenty of revenue coming our way from providing raw material to our partner Ellume and a
precursor to our own antigen test with potential partner as a follow up.

Our partnering discussions will draw from successful launch of Ellume's antibody test which is using our technology. This will greatly de-risk their investment in us, as I see it.

Our own proof of concept and, by now, optimized sensitivity for our antigen test will provide the additional building blocks for successful partnership negotiations which should
be announced as soon as our regulatory framework is up and running.

all IMO